Published in J Surg Res on September 08, 2012
The association between BRAF (V600E) mutation and pathological features in PTC. Eur Arch Otorhinolaryngol (2014) 0.84
Autophagy in thyroid cancer: present knowledge and future perspectives. Front Endocrinol (Lausanne) (2015) 0.82
Anaplastic Thyroid Carcinoma: Current Treatments and Potential New Therapeutic Options with Emphasis on TfR1/CD71. Int J Endocrinol (2014) 0.78
Silencing of UCHL1 by CpG promoter hyper-methylation is associated with metastatic gastroenteropancreatic well-differentiated neuroendocrine (carcinoid) tumors. Ann Surg Oncol (2014) 0.77
The Clinicopathological Features of BRAF Mutated Papillary Thyroid Cancers in Chinese Patients. Int J Endocrinol (2015) 0.77
Effect of BMAP-28 on human thyroid cancer TT cells is mediated by inducing apoptosis. Oncol Lett (2015) 0.76
Thyroid Stimulating Hormone Receptor. Mol Imaging Radionucl Ther (2016) 0.75
Annual Average Changes in Adult Obesity as a Risk Factor for Papillary Thyroid Cancer: A Large-Scale Case-Control Study. Medicine (Baltimore) (2016) 0.75
Mutations of the BRAF gene in human cancer. Nature (2002) 65.42
Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid (2009) 35.34
Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer. Oncogene (2007) 11.85
High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma. Cancer Res (2003) 8.67
Deoxyribonucleic acid profiling analysis of 40 human thyroid cancer cell lines reveals cross-contamination resulting in cell line redundancy and misidentification. J Clin Endocrinol Metab (2008) 5.94
Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy. J Clin Endocrinol Metab (2006) 5.78
The extracellular signal-regulated kinase: multiple substrates regulate diverse cellular functions. Growth Factors (2006) 5.58
BRAF mutation in papillary thyroid cancer: pathogenic role, molecular bases, and clinical implications. Endocr Rev (2007) 5.21
Mutational profile of advanced primary and metastatic radioactive iodine-refractory thyroid cancers reveals distinct pathogenetic roles for BRAF, PIK3CA, and AKT1. Cancer Res (2009) 3.56
Cloning and characterization of the thyroid iodide transporter. Nature (1996) 3.54
BRAF(E600) in benign and malignant human tumours. Oncogene (2007) 2.45
The association of the BRAF(V600E) mutation with prognostic factors and poor clinical outcome in papillary thyroid cancer: a meta-analysis. Cancer (2011) 2.36
Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin in differentiated thyroid carcinoma: results of an international, randomized, controlled study. J Clin Endocrinol Metab (2005) 1.98
Small-molecule MAPK inhibitors restore radioiodine incorporation in mouse thyroid cancers with conditional BRAF activation. J Clin Invest (2011) 1.97
BRAF mutations in papillary thyroid carcinomas inhibit genes involved in iodine metabolism. J Clin Endocrinol Metab (2007) 1.93
Clinicopathologic significance of BRAF V600E mutation in papillary carcinomas of the thyroid: a meta-analysis. Cancer (2007) 1.69
Mutations of the BRAF gene in papillary thyroid carcinoma in a Korean population. Yonsei Med J (2004) 1.63
The BRAFV600E oncogene induces transforming growth factor beta secretion leading to sodium iodide symporter repression and increased malignancy in thyroid cancer. Cancer Res (2009) 1.48
Characterization of the thyroid Na+/I- symporter with an anti-COOH terminus antibody. Proc Natl Acad Sci U S A (1997) 1.44
Suppression of BRAF/MEK/MAP kinase pathway restores expression of iodide-metabolizing genes in thyroid cells expressing the V600E BRAF mutant. Clin Cancer Res (2007) 1.39
B-Raf acts via the ROCKII/LIMK/cofilin pathway to maintain actin stress fibers in fibroblasts. Mol Cell Biol (2004) 1.28
Essential role of B-Raf in ERK activation during extraembryonic development. Proc Natl Acad Sci U S A (2006) 1.28
A perspective view of sodium iodide symporter research and its clinical implications. Eur J Endocrinol (2006) 1.28
Targeting BRAFV600E with PLX4720 displays potent antimigratory and anti-invasive activity in preclinical models of human thyroid cancer. Oncologist (2011) 1.27
BRAFV600E mutation, but not RET/PTC rearrangements, is correlated with a lower expression of both thyroperoxidase and sodium iodide symporter genes in papillary thyroid cancer. Endocr Relat Cancer (2008) 1.26
ERK and beyond: insights from B-Raf and Raf-1 conditional knockouts. Cell Cycle (2006) 1.24
A comparison of 1850 (50 mCi) and 3700 MBq (100 mCi) 131-iodine administered doses for recombinant thyrotropin-stimulated postoperative thyroid remnant ablation in differentiated thyroid cancer. J Clin Endocrinol Metab (2007) 1.23
Insertion of the human sodium iodide symporter to facilitate deep tissue imaging does not alter oncolytic or replication capability of a novel vaccinia virus. J Transl Med (2011) 1.22
Increased expression of the Na+/I- symporter in cultured human thyroid cells exposed to thyrotropin and in Graves' thyroid tissue. J Clin Endocrinol Metab (1997) 1.20
BRAF mutation analysis in fine needle aspiration (FNA) cytology of the thyroid. Diagn Mol Pathol (2006) 1.12
Lymphatic mapping establishes the role of BRAF gene mutation in papillary thyroid carcinoma. Ann Surg (2006) 1.09
Dedifferentiated thyroid cancer: a therapeutic challenge. Biomed Pharmacother (2008) 1.08
Targeting BRAFV600E in thyroid carcinoma: therapeutic implications. Mol Cancer Ther (2007) 1.04
Increasing the effectiveness of radioactive iodine therapy in the treatment of thyroid cancer using Trichostatin A, a histone deacetylase inhibitor. Surgery (2002) 1.01
Standard and emerging therapies for metastatic differentiated thyroid cancer. Oncologist (2010) 1.00
Iodide handling by the thyroid epithelial cell. Exp Clin Endocrinol Diabetes (2001) 0.98
Expression of iodine metabolism genes in human thyroid tissues: evidence for age and BRAFV600E mutation dependency. Clin Endocrinol (Oxf) (2008) 0.95
Identification of borderline thyroid tumors by gene expression array analysis. Cancer (2009) 0.89
Recombinant human thyrotropin (rhTSH) aided radioiodine treatment for residual or metastatic differentiated thyroid cancer. Cochrane Database Syst Rev (2010) 0.85
Surgical site infection and the routine use of perioperative hyperoxia in a general surgical population: a randomized controlled trial. JAMA (2004) 5.44
Effects of limited work hours on surgical training. J Am Coll Surg (2002) 3.82
Selumetinib-enhanced radioiodine uptake in advanced thyroid cancer. N Engl J Med (2013) 3.21
Multimodal silica nanoparticles are effective cancer-targeted probes in a model of human melanoma. J Clin Invest (2011) 1.91
Do benign thyroid nodules have malignant potential? An evidence-based review. World J Surg (2008) 1.85
Incision length for standard thyroidectomy and parathyroidectomy: when is it minimally invasive? Arch Surg (2003) 1.69
Reproducibility of intratumor distribution of (18)F-fluoromisonidazole in head and neck cancer. Int J Radiat Oncol Biol Phys (2008) 1.64
Ipsilateral versus bilateral central neck lymph node dissection in papillary thyroid carcinoma. Ann Surg (2009) 1.62
MIRD Pamphlet No. 22 (abridged): radiobiology and dosimetry of alpha-particle emitters for targeted radionuclide therapy. J Nucl Med (2010) 1.61
MicroRNA analysis as a potential diagnostic tool for papillary thyroid carcinoma. Mod Pathol (2008) 1.60
Mechanical compression of cartilage explants induces multiple time-dependent gene expression patterns and involves intracellular calcium and cyclic AMP. J Biol Chem (2004) 1.56
Parathyroid carcinoma, atypical parathyroid adenoma, or parathyromatosis? Cancer (2007) 1.52
Noninvasive multimodality imaging of the tumor microenvironment: registered dynamic magnetic resonance imaging and positron emission tomography studies of a preclinical tumor model of tumor hypoxia. Neoplasia (2009) 1.52
PET imaging of soluble yttrium-86-labeled carbon nanotubes in mice. PLoS One (2007) 1.43
Risk stratification of indeterminate thyroid fine-needle aspiration biopsy specimens based on mutation analysis. Surgery (2011) 1.43
MIRD pamphlet No. 23: quantitative SPECT for patient-specific 3-dimensional dosimetry in internal radionuclide therapy. J Nucl Med (2012) 1.40
Effects of dynamic compressive loading on chondrocyte biosynthesis in self-assembling peptide scaffolds. J Biomech (2004) 1.37
Classification of follicular thyroid tumors by molecular signature: results of gene profiling. Clin Cancer Res (2003) 1.36
Robotic and endoscopic transaxillary thyroidectomies may be cost prohibitive when compared to standard cervical thyroidectomy: a cost analysis. Surgery (2012) 1.32
Impact of prophylactic central neck lymph node dissection on early recurrence in papillary thyroid carcinoma. World J Surg (2010) 1.32
Dissociable brain mechanisms for processing social exclusion and rule violation. Neuroimage (2010) 1.30
A panel of four miRNAs accurately differentiates malignant from benign indeterminate thyroid lesions on fine needle aspiration. Clin Cancer Res (2012) 1.28
Prophylactic central neck dissection and local recurrence in papillary thyroid cancer: a meta-analysis. Ann Surg Oncol (2010) 1.26
Enhanced neural responses to rule violation in children with autism: a comparison to social exclusion. Dev Cogn Neurosci (2011) 1.24
Positron lymphography: multimodal, high-resolution, dynamic mapping and resection of lymph nodes after intradermal injection of 18F-FDG. J Nucl Med (2012) 1.23
Evaluation of a compartmental model for estimating tumor hypoxia via FMISO dynamic PET imaging. Phys Med Biol (2009) 1.22
Insertion of the human sodium iodide symporter to facilitate deep tissue imaging does not alter oncolytic or replication capability of a novel vaccinia virus. J Transl Med (2011) 1.22
The use of endoscopic ultrasound in the diagnosis of solid pseudopapillary tumors of the pancreas in children. J Pediatr Surg (2002) 1.21
Shear and compression differentially regulate clusters of functionally related temporal transcription patterns in cartilage tissue. J Biol Chem (2006) 1.21
Reducing the object orientation dependence of susceptibility effects in gradient echo MRI through quantitative susceptibility mapping. Magn Reson Med (2012) 1.19
Discrimination of benign and malignant thyroid nodules by molecular profiling. Ann Surg (2004) 1.17
Papillary thyroid carcinoma and microcarcinoma: is there a need to distinguish the two? Thyroid (2009) 1.16
Multimodality registration without a dedicated multimodality scanner. Mol Imaging (2007) 1.16
Molecular profiling distinguishes papillary carcinoma from benign thyroid nodules. J Clin Endocrinol Metab (2004) 1.15
Shear- and compression-induced chondrocyte transcription requires MAPK activation in cartilage explants. J Biol Chem (2007) 1.15
Tumor-specific in vivo transfection with HSV-1 thymidine kinase gene using a Sindbis viral vector as a basis for prodrug ganciclovir activation and PET. J Nucl Med (2006) 1.15
Phase I study of targeted radioimmunotherapy for leptomeningeal cancers using intra-Ommaya 131-I-3F8. J Clin Oncol (2007) 1.14
Robotic-assisted adrenalectomy: what advantages compared to lateral transperitoneal laparoscopic adrenalectomy? Am J Surg (2008) 1.11
Seminars: local and regional anesthesia for thyroid surgery. J Surg Oncol (2006) 1.10
Poorer prognosis and higher prevalence of BRAF (V600E) mutation in synchronous bilateral papillary thyroid carcinoma. Ann Surg Oncol (2011) 1.09
Pharmacokinetics and Biodistribution of (86)Y-Trastuzumab for (90)Y dosimetry in an ovarian carcinoma model: correlative MicroPET and MRI. J Nucl Med (2003) 1.09
Temporal dynamics reveal atypical brain response to social exclusion in autism. Dev Cogn Neurosci (2011) 1.08
How grossed out are you? The neural bases of emotion regulation from childhood to adolescence. Dev Cogn Neurosci (2011) 1.07
Noninvasive molecular imaging of hypoxia in human xenografts: comparing hypoxia-induced gene expression with endogenous and exogenous hypoxia markers. Cancer Res (2008) 1.07
Substernal thyroidectomy is associated with increased morbidity and mortality as compared with conventional cervical thyroidectomy. J Am Coll Surg (2007) 1.04
Organ and fetal absorbed dose estimates from 99mTc-sulfur colloid lymphoscintigraphy and sentinel node localization in breast cancer patients. J Nucl Med (2006) 1.02
Feedback and reward processing in high-functioning autism. Psychiatry Res (2010) 1.01
An unusual allosteric mobility of the C-terminal helix of a high-affinity alphaL integrin I domain variant bound to ICAM-5. Mol Cell (2008) 1.01
Prospective evaluation of 100 robotic-assisted unilateral adrenalectomies. Surgery (2008) 1.00
Tumor size predicts malignant potential in Hürthle cell neoplasms of the thyroid. World J Surg (2008) 0.99
Troglitazone, the peroxisome proliferator-activated receptor-gamma agonist, induces antiproliferation and redifferentiation in human thyroid cancer cell lines. Thyroid (2005) 0.99
Novel therapy for anaplastic thyroid carcinoma cells using an oncolytic vaccinia virus carrying the human sodium iodide symporter. Surgery (2011) 0.97
Preserved reward outcome processing in ASD as revealed by event-related potentials. J Neurodev Disord (2012) 0.97
Imaging hypoxia in orthotopic rat liver tumors with iodine 124-labeled iodoazomycin galactopyranoside PET. Radiology (2008) 0.97
Development of neural systems for processing social exclusion from childhood to adolescence. Dev Sci (2011) 0.96
Chip-based detection of hepatitis C virus using RNA aptamers that specifically bind to HCV core antigen. Biochem Biophys Res Commun (2007) 0.96
Hook needle-guided excision of recurrent differentiated thyroid cancer in previously operated neck compartments: a safe technique for small, nonpalpable recurrent disease. J Clin Endocrinol Metab (2006) 0.96
Parent-adolescent conflict interactions and adolescent alcohol use. Addict Behav (2012) 0.95
Cyclooxygenase-2 expression in thyroid nodules. J Clin Endocrinol Metab (2002) 0.93
Accuracy and reproducibility of tumor positioning during prolonged and multi-modality animal imaging studies. Phys Med Biol (2008) 0.93
A vaccinia virus encoding the human sodium iodide symporter facilitates long-term image monitoring of virotherapy and targeted radiotherapy of pancreatic cancer. J Nucl Med (2012) 0.93
Mapping Tumor Hypoxia In Vivo Using Pattern Recognition of Dynamic Contrast-enhanced MRI Data. Transl Oncol (2012) 0.92
Molecular markers in thyroid cancer diagnostics. Surg Clin North Am (2009) 0.92
Dynamic small-animal PET imaging of tumor proliferation with 3'-deoxy-3'-18F-fluorothymidine in a genetically engineered mouse model of high-grade gliomas. J Nucl Med (2008) 0.92
Are Internet use and video-game-playing addictive behaviors? Biological, clinical and public health implications for youths and adults. Minerva Psichiatr (2012) 0.92
Long-term results of Delorme's procedure and Orr-Loygue rectopexy to treat complete rectal prolapse. Dis Colon Rectum (2005) 0.90
Summary statement: utility of molecular marker testing in thyroid cancer. Surgery (2010) 0.90
Bile acids induce cyclooxygenase-2 expression in human pancreatic cancer cell lines. Carcinogenesis (2003) 0.89
Laparoscopic adrenalectomy after prior abdominal surgery. World J Surg (2008) 0.89
Attachment dismissal predicts frontal slow-wave ERPs during rejection by unfamiliar peers. Emotion (2012) 0.89
Identification of borderline thyroid tumors by gene expression array analysis. Cancer (2009) 0.89
Extrathyroidal extension is not all equal: Implications of macroscopic versus microscopic extent in papillary thyroid carcinoma. Surgery (2008) 0.89
Failure is not an option: Risk-taking is moderated by anxiety and also by cognitive ability in children and adolescents diagnosed with an autism spectrum disorder. J Autism Dev Disord (2011) 0.89
Interleukin-15:Interleukin-15 receptor α scaffold for creation of multivalent targeted immune molecules. Protein Eng Des Sel (2010) 0.88
Molecular analysis of minimally invasive follicular carcinomas by gene profiling. Surgery (2005) 0.88
Microarray analysis of thyroid nodule fine-needle aspirates accurately classifies benign and malignant lesions. J Mol Diagn (2006) 0.88
Adrenocortical carcinoma: the influence of large vessel extension. Surgery (2010) 0.88
Heterotopic pancreatic neoplasm presenting as an obstructing mass at the fourth portion of the duodenum. JOP (2011) 0.87
Effect of hospital volume of thyroidectomies on outcomes following substernal thyroidectomy. World J Surg (2008) 0.87
Does BRAF V600E mutation predict aggressive features in papillary thyroid cancer? Results from four endocrine surgery centers. J Clin Endocrinol Metab (2013) 0.87
Laparoscopic gastric bypass with intestinal malrotation. Obes Surg (2007) 0.87
MIRD pamphlet No. 24: Guidelines for quantitative 131I SPECT in dosimetry applications. J Nucl Med (2013) 0.86